IUPAC and Gedeon Richter, Plc. announce the 2024 IUPAC-Richter Prize in Medicinal Chemistry
The 2024 IUPAC-Richter Prize will be presented during the XXVIII EFMC International Symposium on Medicinal Chemistry (September 1-5, 2024) in Rome (Italy) and the recipient will also give a lecture on the subject of their research at the 38th ACS National Medicinal Chemistry Symposium (June 23-26) in Seattle, WA, United States.
The prize is to be awarded to an internationally recognized scientist, preferably a medicinal chemist, whose activities or published accounts have made an outstanding contribution to the practice of medicinal chemistry or to an outstanding example of new drug discovery.
Prize USD 10,000
The Prize has been established by a generous gift from the Chemical Works of Gedeon Richter, Plc. (Budapest, Hungary) to acknowledge the key role that medicinal chemistry plays toward improving human health.
Applicants should be received by NOMINATION only, with just one person needing to serve in that capacity, although a total of five (5) individuals should be listed as referees overall. The package must be submitted electronically and should contain a complete resume, a professional biography of not more than two pages, and a one-page summary of what the individual considers to be their activities, accomplishments and/or publications that have had the most significant impact upon the field of Medicinal Chemistry. The material will be forwarded confidentially to an independent selection committee appointed by the IUPAC Subcommittee on Medicinal Chemistry and Drug Development.
For further information please contact Prof. Janos Fischer, Member of the IUPAC Sub-committee on Drug Discovery and Development, by email at [email protected]
Nomination materials should be uploaded by 15 December 2023
via this online form
For earlier announcements including awardees presentation, visit this page.
Call for nominations published in Chem Int Oct 2023, p. 31. https://doi.org/10.1515/ci-2023-0410
> See announcement of the winner (posted 31 January 2024)